Delivery Order SPE2DB25D3201-SPE2DB25FNWPV
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a contract ceiling value of $10,113.96. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 30,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $40,455.90 by the Defense Logistics Agency (DLA) for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90 tablets of Januvia 100 mg, valued at $13,040.09. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 5, 2025. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. Januvia is a prescription medication used in diabetes management, consistent with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,091.46 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Januvia 100 mg tablets (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for 90 tablets of Januvia 100 mg by the Defense Logistics Agency (DLA) with a ceiling value of $2,224.88. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 7, 2025, and was awarded on May 6, 2025. This award carries no set-aside designation and represents a competitively awarded procurement. The delivery order is issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 1,000 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract carries a ceiling value of $10,616.60 and was executed on May 30, 2025, with an ultimate completion date of June 2, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Januvia 50 mg tablets in a quantity of 90 units, valued at $11,618.61. The contract was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and utilizes a firm fixed price structure with no set-aside designation. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $27,153.26 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract, effective August 5, 2025, with a completion date of August 6, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWPVDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at approximately $25,949 by the Defense Logistics Agency (DLA) for the supply of Januvia 100 mg tablets (90-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded without set-aside restrictions. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 9/17/25 |